Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting
Hand-out
Press Releases
Dizal Pharmaceutical  
April 1, 2025

Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting

SHANGHAI, April 1, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that results of its

avatar profile Olean Times Herald

Olean Times Herald


Local & Social